retatrutide phase 3 results october 2025 Lilly's triple agonist achieves 16.8% weight loss in trial This data from Phase 3

Tirzepatides superior performance may relate to its additional action on the GIP receptor, providing dual hormonal signalling that enhances metabolic effects

This may include more detailed records of previous weight loss attempts, additional clinical documentation of comorbidities, peer-reviewed literature supporting the medical necessity of GLP-1 treatment, and a detailed letter from your provider explaining why this specific medication is necessary for your care

Both aerobic exercise and resistance training stimulate GLP-1 release

It is natural to wonder: can you safely take a GLP-1 with thyroid issues, or will it complicate your hormone balance even further

If you're in Texas or Utah and want a program that coaches you through side effects instead of leaving you to figure it out, our team can help